In a carefully designed preclinical study, siRNA was used to down-regulate IGF-1R expression in a murine breast cancer cell line and found to decrease proliferation, but also to induce secretion of pro-inflammatory cytokines and to slow down tumor growth in syngenic mice partly by activating anti-tumor immune cell responses [31]. The gene discussed is IGF1R; the disease is neoplasm.